ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer

Expert Panel on Women's Imaging

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

In the management of epithelial ovarian cancers, imaging is used for cancer detection and staging, both before and after initial treatment. The decision of whether to pursue initial cytoreductive surgery for ovarian cancer depends in part on accurate staging. Contrast-enhanced CT of the abdomen and pelvis (and chest where indicated) is the current imaging modality of choice for the initial staging evaluation of ovarian cancer. Fluorine-18-2-fluoro-2-deoxy-D-glucose PET/CT and MRI may be appropriate for problem-solving purposes, particularly when lesions are present on CT but considered indeterminate. In patients who achieve remission, clinical suspicion for relapse after treatment prompts imaging evaluation for recurrence. Contrast-enhanced CT is the modality of choice to assess the extent of recurrent disease, and fluorine-18-2-fluoro-2-deoxy-D-glucose PET/CT is also usually appropriate, as small metastatic foci may be identified. If imaging or clinical examination confirms a recurrence, the extent of disease and timing of disease recurrence then determines the choice of treatments, including surgery, chemotherapy, and radiation therapy. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

Original languageEnglish (US)
Pages (from-to)S198-S207
JournalJournal of the American College of Radiology
Volume15
Issue number5
DOIs
StatePublished - May 1 2018

Fingerprint

Ovarian Neoplasms
Recurrence
Fluorine
Fluorodeoxyglucose F18
Guidelines
Therapeutics
Neoplasm Staging
Expert Testimony
Pelvis
Radiology
Abdomen
Radiotherapy
Thorax
Drug Therapy

Keywords

  • Appropriate Use Criteria
  • Appropriateness Criteria
  • AUC
  • Imaging evaluation
  • Ovarian cancer
  • Recurrence
  • Staging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer. / Expert Panel on Women's Imaging.

In: Journal of the American College of Radiology, Vol. 15, No. 5, 01.05.2018, p. S198-S207.

Research output: Contribution to journalArticle

Expert Panel on Women's Imaging. / ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer. In: Journal of the American College of Radiology. 2018 ; Vol. 15, No. 5. pp. S198-S207.
@article{63dc9921aa954eeda593aae47b68a429,
title = "ACR Appropriateness Criteria{\circledR} Staging and Follow-Up of Ovarian Cancer",
abstract = "In the management of epithelial ovarian cancers, imaging is used for cancer detection and staging, both before and after initial treatment. The decision of whether to pursue initial cytoreductive surgery for ovarian cancer depends in part on accurate staging. Contrast-enhanced CT of the abdomen and pelvis (and chest where indicated) is the current imaging modality of choice for the initial staging evaluation of ovarian cancer. Fluorine-18-2-fluoro-2-deoxy-D-glucose PET/CT and MRI may be appropriate for problem-solving purposes, particularly when lesions are present on CT but considered indeterminate. In patients who achieve remission, clinical suspicion for relapse after treatment prompts imaging evaluation for recurrence. Contrast-enhanced CT is the modality of choice to assess the extent of recurrent disease, and fluorine-18-2-fluoro-2-deoxy-D-glucose PET/CT is also usually appropriate, as small metastatic foci may be identified. If imaging or clinical examination confirms a recurrence, the extent of disease and timing of disease recurrence then determines the choice of treatments, including surgery, chemotherapy, and radiation therapy. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.",
keywords = "Appropriate Use Criteria, Appropriateness Criteria, AUC, Imaging evaluation, Ovarian cancer, Recurrence, Staging",
author = "{Expert Panel on Women's Imaging} and Kang, {Stella K.} and Caroline Reinhold and Mostafa Atri and Benson, {Carol B.} and Bhosale, {Priyadarshani R.} and Anuja Jhingran and Yulia Lakhman and Maturen, {Katherine E.} and Refky Nicola and Pandharipande, {Pari V.} and Salazar, {Gloria M.} and Shipp, {Thomas D.} and Lynn Simpson and William Small and Sussman, {Betsy L.} and Uyeda, {Jennifer W.} and Wall, {Darci J.} and Whitcomb, {Bradford P.} and Zelop, {Carolyn M.} and Phyllis Glanc",
year = "2018",
month = "5",
day = "1",
doi = "10.1016/j.jacr.2018.03.015",
language = "English (US)",
volume = "15",
pages = "S198--S207",
journal = "JACR Journal of the American College of Radiology",
issn = "1558-349X",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer

AU - Expert Panel on Women's Imaging

AU - Kang, Stella K.

AU - Reinhold, Caroline

AU - Atri, Mostafa

AU - Benson, Carol B.

AU - Bhosale, Priyadarshani R.

AU - Jhingran, Anuja

AU - Lakhman, Yulia

AU - Maturen, Katherine E.

AU - Nicola, Refky

AU - Pandharipande, Pari V.

AU - Salazar, Gloria M.

AU - Shipp, Thomas D.

AU - Simpson, Lynn

AU - Small, William

AU - Sussman, Betsy L.

AU - Uyeda, Jennifer W.

AU - Wall, Darci J.

AU - Whitcomb, Bradford P.

AU - Zelop, Carolyn M.

AU - Glanc, Phyllis

PY - 2018/5/1

Y1 - 2018/5/1

N2 - In the management of epithelial ovarian cancers, imaging is used for cancer detection and staging, both before and after initial treatment. The decision of whether to pursue initial cytoreductive surgery for ovarian cancer depends in part on accurate staging. Contrast-enhanced CT of the abdomen and pelvis (and chest where indicated) is the current imaging modality of choice for the initial staging evaluation of ovarian cancer. Fluorine-18-2-fluoro-2-deoxy-D-glucose PET/CT and MRI may be appropriate for problem-solving purposes, particularly when lesions are present on CT but considered indeterminate. In patients who achieve remission, clinical suspicion for relapse after treatment prompts imaging evaluation for recurrence. Contrast-enhanced CT is the modality of choice to assess the extent of recurrent disease, and fluorine-18-2-fluoro-2-deoxy-D-glucose PET/CT is also usually appropriate, as small metastatic foci may be identified. If imaging or clinical examination confirms a recurrence, the extent of disease and timing of disease recurrence then determines the choice of treatments, including surgery, chemotherapy, and radiation therapy. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

AB - In the management of epithelial ovarian cancers, imaging is used for cancer detection and staging, both before and after initial treatment. The decision of whether to pursue initial cytoreductive surgery for ovarian cancer depends in part on accurate staging. Contrast-enhanced CT of the abdomen and pelvis (and chest where indicated) is the current imaging modality of choice for the initial staging evaluation of ovarian cancer. Fluorine-18-2-fluoro-2-deoxy-D-glucose PET/CT and MRI may be appropriate for problem-solving purposes, particularly when lesions are present on CT but considered indeterminate. In patients who achieve remission, clinical suspicion for relapse after treatment prompts imaging evaluation for recurrence. Contrast-enhanced CT is the modality of choice to assess the extent of recurrent disease, and fluorine-18-2-fluoro-2-deoxy-D-glucose PET/CT is also usually appropriate, as small metastatic foci may be identified. If imaging or clinical examination confirms a recurrence, the extent of disease and timing of disease recurrence then determines the choice of treatments, including surgery, chemotherapy, and radiation therapy. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

KW - Appropriate Use Criteria

KW - Appropriateness Criteria

KW - AUC

KW - Imaging evaluation

KW - Ovarian cancer

KW - Recurrence

KW - Staging

UR - http://www.scopus.com/inward/record.url?scp=85046978149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046978149&partnerID=8YFLogxK

U2 - 10.1016/j.jacr.2018.03.015

DO - 10.1016/j.jacr.2018.03.015

M3 - Article

AN - SCOPUS:85046978149

VL - 15

SP - S198-S207

JO - JACR Journal of the American College of Radiology

JF - JACR Journal of the American College of Radiology

SN - 1558-349X

IS - 5

ER -